BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/12/2019 10:38:56 AM | Browse: 962 | Download: 1177
 |
Received |
|
2019-05-02 05:25 |
|
Peer-Review Started |
|
2019-05-05 02:07 |
|
To Make the First Decision |
|
2019-06-11 03:31 |
|
Return for Revision |
|
2019-06-26 15:01 |
|
Revised |
|
2019-07-02 00:40 |
|
Second Decision |
|
2019-08-06 07:17 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-08-07 04:05 |
|
Articles in Press |
|
2019-08-07 04:05 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-09-04 01:17 |
|
Publish the Manuscript Online |
|
2019-09-12 10:38 |
| ISSN |
2220-3141(online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Critical Care Medicine |
| Manuscript Type |
Review |
| Article Title |
Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: The role of inflammatory biomarkers
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Sarah Chalmers, Ali Khawaja, Patrick M Wieruszewski, Ognjen Gajic and Yewande Odeyemi |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sarah Chalmers, MD, Academic Fellow, Division of Pulmonary and Critical Care Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States. chalmers.sarah@mayo.edu |
| Key Words |
Acute pulmonary inflammation; Inflammatory biomarkers; Acute respiratory distress syndrome; Pneumonia; Critical illness; Diagnosis |
| Core Tip |
Community acquired pneumonia and acute respiratory distress syndrome are common and important causes of respiratory failure in the intensive care unit. Both clinical entities are characterized by acute pulmonary inflammation in response to direct or indirect lung injury and current evidence suggests a role of biomarkers for the assessment of severity, and distinguishing sub-phenotypes (hyper-inflammatory versus hypo-inflammatory) with important prognostic and therapeutic implications. |
| Publish Date |
2019-09-12 10:38 |
| Citation |
Chalmers S, Khawaja A, Wieruszewski PM, Gajic O, and Odeyemi Y. Diagnosis and treatment of acute pulmonary inflammation in critically ill patients: The role of inflammatory biomarkers World J Crit Care Med 2019; 8(5): 59-71 |
| URL |
https://www.wjgnet.com/2220-3141/full/v8/i5/59.htm |
| DOI |
https://dx.doi.org/10.5492/wjccm.v8.i5.59 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
